Source: Clinics. Unidade: FMRP
Subjects: PANDEMIAS, COVID-19, NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO TARDIO
ABNT
MÜHLMANN, Lindson et al. Delayed diagnosis and increased mortality risk: assessing the effects of the COVID-19 pandemic on breast cancer recurrence. Clinics, v. 79, p. 1-6, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2024.100340. Acesso em: 04 maio 2026.APA
Mühlmann, L., Pimentel, F. F., Tiezzi, D. G., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2024). Delayed diagnosis and increased mortality risk: assessing the effects of the COVID-19 pandemic on breast cancer recurrence. Clinics, 79, 1-6. doi:10.1016/j.clinsp.2024.100340NLM
Mühlmann L, Pimentel FF, Tiezzi DG, Carrara HHA, Andrade JM de, Reis FJC dos. Delayed diagnosis and increased mortality risk: assessing the effects of the COVID-19 pandemic on breast cancer recurrence [Internet]. Clinics. 2024 ; 79 1-6.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.clinsp.2024.100340Vancouver
Mühlmann L, Pimentel FF, Tiezzi DG, Carrara HHA, Andrade JM de, Reis FJC dos. Delayed diagnosis and increased mortality risk: assessing the effects of the COVID-19 pandemic on breast cancer recurrence [Internet]. Clinics. 2024 ; 79 1-6.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.clinsp.2024.100340
